Insights

Financial Stability Agenus secured a $22 million mortgage and is undergoing a strategic operational realignment, indicating a strong financial position for potential investments or partnerships.

Market Trend Potential Despite recent stock price fluctuations, analysts suggest Agenus may be at a point of trend reversal, presenting an opportunity for potential buyers or investors.

Competitive Positioning With a focus on immuno-oncology and a comprehensive pipeline of agents, Agenus competes with similar companies like Innate Pharma, PureTech Health, Cullinan Therapeutics, and MorphoSys, offering potential partnership opportunities.

Technology Utilization Agenus utilizes a tech stack including WordPress, Microsoft tools, and Base SAS, showcasing potential technology integration or service opportunities for tech providers.

Employee Engagement With a workforce of 201-500 employees and a mission to expand cancer immunotherapy, Agenus presents potential recruitment or training opportunities for HR and employee engagement service providers.

Agenus Tech Stack

Agenus uses 8 technology products and services including WordPress, ADP, Exhibit, and more. Explore Agenus's tech stack below.

  • WordPress
    Content Management System
  • ADP
    Human Resource Management System
  • Exhibit
    Javascript Graphics
  • Microsoft
    Miscellaneous
  • reCAPTCHA
    Security
  • Base SAS
    Software As A Service
  • Microsoft Exchange
    Storage
  • Microsoft Teams
    Team Collaboration

Media & News

Agenus's Email Address Formats

Agenus uses at least 1 format(s):
Agenus Email FormatsExamplePercentage
First.Last@agenusbio.comJohn.Doe@agenusbio.com
90%
FLast@agenusbio.comJDoe@agenusbio.com
9%
First.Middle@agenusbio.comJohn.Michael@agenusbio.com
1%

Frequently Asked Questions

Where is Agenus's headquarters located?

Minus sign iconPlus sign icon
Agenus's main headquarters is located at 3 Forbes Road Lexington, Massachusetts 02421 US. The company has employees across 5 continents, including North AmericaEuropeAsia.

What is Agenus's phone number?

Minus sign iconPlus sign icon
You can contact Agenus's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Agenus's stock symbol?

Minus sign iconPlus sign icon
Agenus is a publicly traded company; the company's stock symbol is AGEN.

What is Agenus's official website and social media links?

Minus sign iconPlus sign icon
Agenus's official website is agenusbio.com and has social profiles on LinkedIn.

How much revenue does Agenus generate?

Minus sign iconPlus sign icon
As of November 2024, Agenus's annual revenue reached $75M.

What is Agenus's SIC code NAICS code?

Minus sign iconPlus sign icon
Agenus's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Agenus have currently?

Minus sign iconPlus sign icon
As of November 2024, Agenus has approximately 298 employees across 5 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: R. D.Chief Commercial Officer: R. T.Chief People Officer (chro): T. C.. Explore Agenus's employee directory with LeadIQ.

What industry does Agenus belong to?

Minus sign iconPlus sign icon
Agenus operates in the Biotechnology Research industry.

What technology does Agenus use?

Minus sign iconPlus sign icon
Agenus's tech stack includes WordPressADPExhibitMicrosoftreCAPTCHABase SASMicrosoft ExchangeMicrosoft Teams.

What is Agenus's email format?

Minus sign iconPlus sign icon
Agenus's email format typically follows the pattern of . Find more Agenus email formats with LeadIQ.

How much funding has Agenus raised to date?

Minus sign iconPlus sign icon
As of November 2024, Agenus has raised $75M in funding. The last funding round occurred on May 07, 2024 for $75M.

When was Agenus founded?

Minus sign iconPlus sign icon
Agenus was founded in 1994.
Agenus

Agenus

Biotechnology ResearchMassachusetts, United States201-500 Employees

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. 

For more information, visit www.agenusbio.com or follow us at @agenus_bio. 

Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/

Section iconCompany Overview

Headquarters
3 Forbes Road Lexington, Massachusetts 02421 US
Phone number
SIC Code
2836 - Biological Products, Except Diagnostic Substances
Stock Symbol
AGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
201-500

Section iconFunding & Financials

  • $75M

    Agenus has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 07, 2024 in the amount of $75M.

  • $50M$100M

    Agenus's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $75M

    Agenus has raised a total of $75M of funding over 8 rounds. Their latest funding round was raised on May 07, 2024 in the amount of $75M.

  • $50M$100M

    Agenus's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.